Πέμπτη 19 Απριλίου 2018

High-dose chemotherapy followed by autologous transplantation may overcome the poor prognosis of diffuse large B-cell lymphoma patients with MYC/BCL2 co-expression.

http:--www.nature.com-images-lo_npg.gif https:--www.ncbi.nlm.nih.gov-corehtml-pm Related Articles

High-dose chemotherapy followed by autologous transplantation may overcome the poor prognosis of diffuse large B-cell lymphoma patients with MYC/BCL2 co-expression.

Blood Cancer J. 2016 11 04;6(11):e491

Authors: Maura F, Guidetti A, Pellegrinelli A, Dodero A, Pennisi M, Caprioli C, Testi A, Farina L, Bolli N, Devizzi LF, Cabras A, Corradini P

PMID: 27813532 [PubMed - indexed for MEDLINE]



https://ift.tt/2fm4q1w

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου